Critical Role of Anti-Angiogenesis and VEGF Inhibition in Colorectal Cancer : Supplement Issue: Oncology 2005, Vol. 69, Suppl. 3 / Díaz-Rubio, E. (EDT)/ Schmoll, H.-J. (EDT)

ホーム
> 洋書
> 英文書
> Medical

Critical Role of Anti-Angiogenesis and VEGF Inhibition in Colorectal Cancer : Supplement Issue: Oncology 2005, Vol. 69, Suppl. 3

ポイントキャンペーン

Critical Role of Anti-Angiogenesis and VEGF Inhibition in Colorectal Cancer : Supplement Issue: Oncology 2005, Vol. 69, Suppl. 3

Díaz-Rubio, E. (EDT)/ Schmoll, H.-J. (EDT)

S Karger AG（2005/11発売）

ただいまウェブストアではご注文を受け付けておりません。 ⇒古書を探す

製本 Paperback:紙装版/ペーパーバック版／ページ数 56 p.
言語 ENG
商品コード 9783805580472
DDC分類 616.994347

基本説明

Supplement Issue: Oncology 2005, Vol. 69, Suppl. 3.

Introduction: Diaz-Rubio, E.; Schmoll, H.-J.; VEGF as a Key Mediator of Angiogenesis in Cancer: Carmeliet, P.; VEGF as a Therapeutic Target in Cancer: Ferrara, N.; Bevacizumab Combined with Standard Fluoropyrimidine-Based Chemotherapy Regimens to Treat Colorectal Cancer: Hurwitz, H.; Kabbinavar, F.; Managing Patients Treated with Bevacizumab Combination Therapy: Gordon, M.S.; Cunningham, D.; The Future Development of Bevacizumab in Colorectal Cancer: Diaz-Rubio, E.; Schmoll, H.-J.; Investigating the Potential of Bevacizumab in Other Indications: Metastatic Renal Cell, Non-Small Cell Lung, Pancreatic and Breast Cancer: de Gramont, A.; Van Cutsem, E.